IGC Pharma, Inc. — Director's Dealing 2026

Jan 20, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IGC Pharma, Inc. (IGC)
CIK: 0001326205
Period of Report: 2026-01-19

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-19	Common Stock	M	100000	$0.0	Acquired	1371251	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-01-19	Restricted Stock Units	$	M	100000	Disposed		Common Stock (100000)	Direct

Footnotes

F1: On March 13, 2024, the Reporting Person was granted RSUs subject to vesting according to specific milestones set by the Company's Board of Directors. The RSUs vest when milestones are achieved.

F2: Each restricted stock unit represents a right to receive one share of IGC common stock.